Khaled Z Abd-Elmoniem

Dr. Khaled Z Abd-Elmoniem

National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2002 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
KAK.Z. Abd-Elmoniem
K.Z. Abd-Elmoniem
AYA.-B.M. Youssef
A.-B.M. Youssef
YKYasser Mostafa Kadah
Yasser Mostafa Kadah
This paper presents a novel approach for speckle reduction and coherence enhancement of ultrasound images based on nonlinear coherent diffusion (NCD) model. The proposed NCD model combines three different models. According to speckle extent and image anisotropy, the NCD model changes progressively from isotropic diffusion through anisotropic coherent diffusion to, finally, mean curvature motion. This structure maximally low-pass filters those parts of the image that correspond to fully developed speckle, while substantially preserving information associated with resolved-object structures. The proposed implementation algorithm utilizes an efficient discretization scheme that allows for real-time implementation on commercial systems. The theory and implementation of the new technique are presented and verified using phantom and clinical ultrasound images. In addition, the results from previous techniques are compared with the new method to demonstrate its performance.

1 January 2012 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
KAKhaled Z Abd-Elmoniem
Khaled Z Abd-Elmoniem
Miguel Santaularia-TomasMiguel Santaularia-Tomas
Miguel Santaularia-Tomas
TSTetsuo Sasano
Tetsuo Sasano
SSSahar Soleimanifard
Sahar Soleimanifard
EVEvert-Jan P Vonken
Evert-Jan P Vonken
MAM Roselle Abraham
M Roselle Abraham
We sought to investigate the relationship between infarct and dyssynchrony post- myocardial infarct (MI), in a porcine model. Mechanical dyssynchrony post-MI is associated with left ventricular (LV) remodeling and increased mortality. Cine, gadolinium-contrast, and tagged cardiovascular magnetic resonance (CMR) were performed pre-MI, 9 ± 2 days (early post-MI), and 33 ± 10 days (late post-MI) post-MI in 6 pigs to characterize cardiac morphology, location and extent of MI, and regional mechanics. LV mechanics were assessed by circumferential strain (eC). Electro-anatomic mapping (EAM) was performed within 24 hrs of CMR and prior to sacrifice. Mean infarct size was 21 ± 4% of LV volume with evidence of post-MI remodeling. Global eC significantly decreased post MI (-27 ± 1.6% vs. -18 ± 2.5% (early) and -17 ± 2.7% (late), p < 0.0001) with no significant change in peri-MI and MI segments between early and late time-points. Time to peak strain (TTP) was significantly longer in MI, compared to normal and peri-MI segments, both early (440 ± 40 ms vs. 329 ± 40 ms and 332 ± 36 ms, respectively; p = 0.0002) and late post-MI (442 ± 63 ms vs. 321 ± 40 ms and 355 ± 61 ms, respectively; p = 0.012). The standard deviation of TTP in 16 segments (SD16) significantly increased post-MI: 28 ± 7 ms to 50 ± 10 ms (early, p = 0.012) to 54 ± 19 ms (late, p = 0.004), with no change between early and late post-MI time-points (p = 0.56). TTP was not related to reduction of segmental contractility. EAM revealed late electrical activation and greatly diminished conduction velocity in the infarct (5.7 ± 2.4 cm/s), when compared to peri-infarct (18.7 ± 10.3 cm/s) and remote myocardium (39 ± 20.5 cm/s). Mechanical dyssynchrony occurs early after MI and is the result of delayed electrical and mechanical activation in the infarct.

30 July 2018 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
RSRalph Sinkus
Ralph Sinkus
SLSimon Lambert
Simon Lambert
KAKhaled Z Abd-Elmoniem
Khaled Z Abd-Elmoniem
CMCaryn Morse
Caryn Morse
THTheo Heller
Theo Heller
AGAhmed M Gharib
Ahmed M Gharib

1 December 2008 in Medical Image Analysis
Verified
Journal Article
Closed access
KAKhaled Z. Abd-Elmoniem
Khaled Z. Abd-Elmoniem
MSMatthias Stuber
Matthias Stuber
JPJerry L Prince
Jerry L Prince

23 July 2020 in JCI Insight
Verified
Journal Article
Closed access
PDF file
ABAnnah P. Baykal
Annah P. Baykal
EPElizabeth Parks
Elizabeth Parks
RSRobert Shamburek
Robert Shamburek
MSMajid Mufaqam Syed-Abdul
Majid Mufaqam Syed-Abdul
SCShaji Chacko
Shaji Chacko
RBRebecca J. Brown
Rebecca J. Brown
De novo lipogenesis (DNL) plays a role in the development of hepatic steatosis. In humans with lipodystrophy, reduced adipose tissue causes lower plasma leptin, insulin resistance, dyslipidemia, and ectopic triglyceride (TG) accumulation. We hypothesized that recombinant leptin (metreleptin) for 6 months in 11 patients with lipodystrophy would reduce DNL by decreasing insulin resistance and glycemia, thus reducing circulating TG and hepatic TG. The percentage of TG in TG-rich lipoprotein particle (TRLP-TG) derived from DNL (%DNL) was measured by deuterium incorporation from body water into palmitate. At baseline, DNL was elevated, similar to levels previously shown in obesity-associated nonalcoholic fatty liver disease (NAFLD). After metreleptin, DNL decreased into the normal range. Similarly, absolute DNL (TRLP-TG × %DNL) decreased by 88% to near-normal levels. Metreleptin improved peripheral insulin sensitivity (hyperinsulinemic-euglycemic clamp) and lowered hemoglobin A1c and hepatic TG. Both before and after metreleptin, DNL positively correlated with insulin resistance, insulin doses, and hepatic TG, supporting the hypothesis that hyperinsulinemia stimulates DNL and that elevated DNL is integral to the pathogenesis of lipodystrophy-associated NAFLD. These data suggest that leptin-mediated improvement in insulin sensitivity increases clearance of blood glucose by peripheral tissues, reduces hepatic carbohydrate flux, and lowers insulinemia, resulting in DNL reductions and improvements in hepatic steatosis and dyslipidemia.

25 August 2014 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
KAK. Z. Abd-Elmoniem
K. Z. Abd-Elmoniem
AUA. B. Unsal
A. B. Unsal
SES. Eshera
S. Eshera
JMJ. R. Matta
J. R. Matta
NMN. Muldoon
N. Muldoon
AGAhmed M Gharib
Ahmed M Gharib
Individuals with long-term human immunodeficiency virus (HIV) infection are at risk for premature vasculopathy and cardiovascular disease (CVD). We evaluated coronary vessel wall thickening, coronary plaque, and epicardial fat in patients infected with HIV early in life compared with healthy controls. This is a prospective cross-sectional study of 35 young adults who acquired HIV in early life and 11 healthy controls, free of CVD. Time resolved phase-sensitive dual inversion recovery black-blood vessel wall magnetic resonance imaging (TRAPD) was used to measure proximal right coronary artery (RCA) wall thickness, and multidetector computed tomography (CT) angiography was used to quantify coronary plaque and epicardial fat. RCA vessel wall thickness was significantly increased in HIV-infected patients compared with sex- and race-matched controls (1.32 ± 0.21 mm vs 1.09 ± 0.14 mm, P = .002). No subject had discrete plaque on CT sufficient to cause luminal narrowing, and plaque was not related to RCA wall thickness. In multivariate regression analyses, smoking pack-years (P = .004) and HIV infection (P = .007) were independently associated with thicker RCA vessel walls. Epicardial fat did not differ between groups. Among the HIV-infected group, duration of antiretroviral therapy (ART) (P = .02), duration of stavudine exposure (P < .01), low-density lipoprotein cholesterol (P = .04), and smoking pack-years (P < .01) were positively correlated with RCA wall thickness. This investigation provides evidence of subclinical coronary vascular disease among individuals infected with HIV in early life. Increased duration of ART, hyperlipidemia, and smoking contributed to proximal RCA thickening, independent of atherosclerotic plaque quantified by CT. These modifiable risk factors appear to influence early atherogenesis as measured by coronary wall thickness and may be important targets for CVD risk reduction.